Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldosterone Antagonist Chronic Hemodialysis Interventional Survival Trial
2012-002856-18Phase 3Active
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of spironolactone in chronic kidney disease (CKD) and end-stage kidney disease (ESKD), sponsored by Centre Hospitalier Universitaire de Brest. Started Jun 2013; status: active.
02
Drugs
spironolactone
03
Conditions
chronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2012-002856-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002856-18.